openPR Logo
Press release

Haemorrhoid Ligators (rubber band ligation) Market Size, Sales, Average Price and Trends Analysis, till 2032

05-13-2025 11:39 AM CET | Health & Medicine

Press release from: Datavagyanik Business Intelligence

Haemorrhoid Ligators (rubber band ligation) Market Size,

Haemorrhoid Ligators (rubber band ligation) Market Size is estimated to be $140million in 2024 and is expected to grow at an average yearly rate of around 4% during the timeframe (2025-2032).

Monitor Country-wise Haemorrhoid Ligators (rubber band ligation) Sales and Demand with Our Comprehensive Haemorrhoid Ligators (rubber band ligation) Sales Database

Gain in-depth insights into the Haemorrhoid Ligators (rubber band ligation) Sales landscape across 20+ countries with our specialized Haemorrhoid Ligators (rubber band ligation) Sales Database. Stay ahead in the market by tracking country-wise Haemorrhoid Ligators (rubber band ligation) Sales, identifying key manufacturers.

Extensive Haemorrhoid Ligators (rubber band ligation) Sales database covering 20+ countries worldwide, Haemorrhoid Ligators (rubber band ligation) Sales trends

Haemorrhoid Ligators (rubber band ligation) market revenue tracker by country

Stay Updated with Haemorrhoid Ligators (rubber band ligation) Sales Trends

Track real-time Haemorrhoid Ligators (rubber band ligation) prices, analyze Haemorrhoid Ligators (rubber band ligation) price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.

The research and analytics firm Datavagyanik released the updated version of its report on "Haemorrhoid Ligators (rubber band ligation) Market - Detailed Analysis, Business Opportunities and Forecasts".

Request sample at https://datavagyanik.com/reports/haemorrhoid-ligators-rubber-band-ligation-market/



Haemorrhoid Ligators (rubber band ligation) sales trend in 2024 vs 2025

The global market for haemorrhoid ligators, especially rubber band ligation devices, has shown a notable upward trajectory from 2024 to 2025. This growth is largely driven by an increase in patient awareness, a growing demand for non-surgical procedures, and improved healthcare access across various regions. Rubber band ligation remains one of the most effective, minimally invasive procedures for treating internal hemorrhoids, and its simplicity continues to attract both healthcare providers and patients.

Overview of 2024 Sales Trends

In 2024, sales of haemorrhoid ligators grew steadily due to rising awareness around digestive health and hemorrhoid management. Medical practitioners favored rubber band ligation for its low cost, minimal downtime, and effectiveness, especially in outpatient settings. As a result, clinics and ambulatory surgical centers increased procurement of these devices. The year also saw modest growth in developed markets where advanced diagnostic practices led to earlier detection of hemorrhoids, thereby increasing the number of procedures performed.

In terms of regional dynamics, North America and Europe held a significant share of the market due to well-established healthcare systems and higher procedural volumes. Additionally, private health insurance often covered minimally invasive treatments, which made rubber band ligation more accessible to patients.

Growth and Trends in 2025

Moving into 2025, sales of haemorrhoid ligators are expected to rise at a more accelerated pace. One of the key contributing factors is the increasing demand for outpatient care. As healthcare systems globally shift focus toward reducing hospitalization time and costs, procedures like rubber band ligation that can be performed in clinics are gaining traction. The year 2025 also marks a stronger emergence of demand from developing regions in Asia-Pacific, Latin America, and parts of Africa. These regions are experiencing improvements in healthcare infrastructure and patient education, leading to increased diagnosis and treatment of hemorrhoids.

Technological enhancements in ligation devices-such as multi-band applicators and user-friendly kits-have also made the procedure more efficient and less dependent on surgical expertise. This has broadened the scope of usage among general practitioners and colorectal specialists alike. Furthermore, there is a notable shift toward disposable and single-use ligation devices due to growing concerns around hygiene and infection control, particularly in post-pandemic healthcare protocols. These newer devices tend to be priced slightly higher, contributing to an overall increase in market revenue.

Marketing efforts by medical device manufacturers have also played a role in pushing up sales. Educational campaigns targeting both professionals and patients have demystified the procedure, making more people open to seeking early intervention.



Request for customization https://datavagyanik.com/reports/haemorrhoid-ligators-rubber-band-ligation-market/



Haemorrhoid Ligators (rubber band ligation) Market Definition

The haemorrhoid ligators market refers to the global industry focused on the development, production, and sale of medical devices used for the non-surgical treatment of internal hemorrhoids through rubber band ligation. This market is a specialized segment within the broader field of gastrointestinal and colorectal healthcare solutions. It caters to hospitals, ambulatory surgical centers, outpatient clinics, and other healthcare providers that treat hemorrhoids, which are swollen veins in the anus that can cause pain, itching, and bleeding.

Rubber band ligation is a minimally invasive procedure used primarily for treating internal hemorrhoids. In this procedure, a ligator device is used to place a small rubber band around the base of the hemorrhoid. This band cuts off the blood supply to the hemorrhoid, causing it to shrink and eventually fall off, usually within a week. The procedure is considered quick, cost-effective, and safe, making it a preferred treatment method for grades I to III internal hemorrhoids. Due to its simplicity and efficiency, rubber band ligation can be performed without anesthesia and in outpatient settings, allowing patients to return to normal activities within a short time.

The haemorrhoid ligators market is defined by several key components:

1. Product Types

The market includes a variety of ligator devices such as:

Endoscopic ligators: Used during colonoscopy or sigmoidoscopy procedures.

Non-endoscopic ligators: Used without imaging guidance, often in outpatient settings.

Single-use ligators: Designed for infection control and convenience.

Reusable ligators: More cost-effective for high-volume practices.

These product variations cater to the diverse preferences of healthcare providers based on clinical setting, budget, and patient demographics.

2. End-User Segmentation

End-users of haemorrhoid ligator devices include:

Hospitals: Often handle more complex or advanced cases requiring additional monitoring.

Ambulatory surgical centers: Specialized facilities that focus on outpatient surgical procedures.

Clinics and private practices: Provide quick and accessible treatment for early-stage hemorrhoids.

This segmentation reflects the widespread applicability of rubber band ligation across different healthcare environments.

3. Geographical Reach

The market spans developed and developing regions, with North America and Europe leading in device adoption due to advanced healthcare systems. However, emerging markets in Asia-Pacific, Latin America, and parts of Africa are showing significant growth potential as awareness and access to healthcare services improve.

4. Market Drivers

The growth of the haemorrhoid ligators market is driven by:

Increasing prevalence of hemorrhoids due to lifestyle factors such as low-fiber diets and sedentary behavior.

Rising preference for non-surgical, outpatient procedures.

Technological advancements in ligation devices.

Greater focus on cost-effective treatment methods in public health systems.

5. Challenges and Considerations

Despite the advantages, the market also faces challenges such as limited access in rural areas, the need for skilled practitioners, and occasional post-procedural complications like pain or bleeding. Nevertheless, ongoing innovation and healthcare training programs continue to expand the market's reach and effectiveness.



Important target segments driving the demand for Haemorrhoid Ligators (rubber band ligation) Market

The demand for haemorrhoid ligators, particularly rubber band ligation devices, is being fueled by specific target segments within the healthcare ecosystem. Understanding these segments is critical for manufacturers, suppliers, and healthcare providers as they align strategies to meet growing needs and tap into new opportunities. These target groups represent both the patient population and the healthcare institutions involved in the delivery of this minimally invasive treatment for internal hemorrhoids.

1. Middle-Aged and Elderly Population

One of the most significant consumer segments driving demand is the middle-aged and elderly population, typically aged 40 and above. Hemorrhoids become more common with age due to weakening of rectal tissues and chronic straining during bowel movements. With a growing global elderly demographic, particularly in countries with aging populations like Japan, Italy, and Germany, there is an increasing number of individuals seeking effective, low-risk treatments. Rubber band ligation fits this need well, offering a quick, outpatient solution without the risks associated with major surgery.

2. Sedentary Lifestyle Professionals

Urban professionals with sedentary jobs are another important segment. Office workers who sit for prolonged periods are at greater risk of developing hemorrhoids due to increased pressure in the rectal area. This demographic often seeks fast, low-downtime procedures, making rubber band ligation an ideal treatment. Additionally, these individuals are more likely to seek private healthcare services, where outpatient procedures are common, thereby increasing demand for ligators in urban clinics and specialized centers.

3. Healthcare Facilities: Outpatient Clinics and Ambulatory Surgical Centers

On the institutional side, outpatient clinics and ambulatory surgical centers are key drivers of demand for haemorrhoid ligators. These facilities are designed to deliver same-day procedures and increasingly prioritize non-surgical solutions that reduce recovery time and cost. Rubber band ligation requires minimal equipment and staff training, making it highly attractive for such centers. As more patients prefer outpatient care for convenience and affordability, these settings continue to expand their capacity and need for ligator devices.

4. Primary Care Providers and Gastroenterologists

Primary care providers and gastroenterologists are often the first point of contact for patients with hemorrhoid symptoms. As awareness of rubber band ligation grows, these healthcare professionals are adopting ligator tools to offer in-clinic treatment rather than referring patients to surgical centers. This shift allows for faster treatment and enhances patient satisfaction. The growing use of ligators by general practitioners is expanding the market beyond traditional hospital settings.

5. Health-Conscious Individuals in Emerging Markets

In emerging economies, rising health awareness and increasing access to healthcare are creating new demand segments. Educated, health-conscious individuals in urban areas of countries like India, China, and Brazil are seeking timely and effective treatment for common conditions like hemorrhoids. As healthcare infrastructure improves in these regions, clinics and hospitals are investing in ligation devices to meet this new wave of demand.



Key Players in Haemorrhoid Ligators (rubber band ligation), Market Share

The haemorrhoid ligators market, specifically rubber band ligation devices, is a niche but rapidly growing segment within the global medical device industry. As the demand for non-surgical, cost-effective treatments increases, particularly for conditions like internal hemorrhoids, major medical device manufacturers have entered or expanded their presence in this field. The market is defined by intense competition, ongoing product innovation, and a strong focus on outpatient care.

Several key players dominate this market, each bringing unique strengths that shape the competitive landscape. While exact market share figures may fluctuate across regions and product categories, certain companies consistently stand out due to their broad product offerings, established distribution channels, and strategic investment in research and development.

Ethicon (a subsidiary of Johnson & Johnson)

Ethicon is one of the most recognized names in surgical and minimally invasive devices. Its parent company, Johnson & Johnson, gives it significant financial and operational backing. Ethicon's ligation tools are known for reliability and ease of use. Their reputation for quality and extensive surgeon training programs helps drive strong adoption of their haemorrhoid ligators globally. Their market presence is especially robust in hospitals and teaching institutions, where product standardization and trusted brands are preferred.

Medtronic

Medtronic is another major force in the medical device industry and has made significant strides in gastrointestinal and colorectal care. While the company is known for advanced surgical instruments and robotic platforms, it also offers rubber band ligators designed for outpatient use. Medtronic's emphasis on product ergonomics and usability in high-volume environments contributes to its growing market share. Its global footprint ensures accessibility to its ligators across both developed and emerging markets.

Cook Medical

Cook Medical is widely recognized for its specialization in minimally invasive procedures. Their haemorrhoid ligators are designed for clinical efficiency, especially in ambulatory care settings. Cook has established a strong presence in the gastrointestinal treatment segment and continues to innovate with devices that improve the comfort and effectiveness of procedures like rubber band ligation. Cook's strength lies in targeting smaller clinics and day surgery centers, which are seeing a surge in demand for low-risk, quick procedures.

Boston Scientific

Boston Scientific focuses on high-performance tools for endoscopic and gastrointestinal procedures. Its ligator devices are often used in combination with diagnostic equipment in endoscopy suites. Boston Scientific's market strength is supported by its deep ties with specialist physicians and its long-standing role in GI treatment innovation. The company benefits from its comprehensive portfolio, often bundling its products for hospital systems.

Smaller and Emerging Players

Smaller players such as CONMED, Privi Medical, Sklar Surgical Instruments, and Integra LifeSciences also have a meaningful presence in the ligator space. These companies often serve niche markets or introduce highly specialized, user-friendly devices that appeal to outpatient clinics and private practices. Privi Medical, for instance, is known for developing simplified, compact ligators for use in resource-constrained environments or by general practitioners.



Key Questions Answered in the Haemorrhoid Ligators (rubber band ligation) market report:

What is the total global Haemorrhoid Ligators (rubber band ligation) Sales volume, and how has it changed over the past five years?

What is Haemorrhoid Ligators (rubber band ligation) price trend, what has been the historical prices?

What will be the Haemorrhoid Ligators (rubber band ligation) price trend in 2025?

Which countries have the highest Haemorrhoid Ligators (rubber band ligation) Sales, and what factors contribute to their dominance in the market?

How does Haemorrhoid Ligators (rubber band ligation) Sales vary across key manufacturers, and what expansions have been observed recently?

What is the current global revenue generated from Haemorrhoid Ligators (rubber band ligation) Sales, and how does it compare to previous years?

Which industries drive the highest demand for Haemorrhoid Ligators (rubber band ligation), and how is this demand expected to evolve in the next five years?

What are the major challenges impacting Haemorrhoid Ligators (rubber band ligation) Sales and supply chain operations across key markets?

How do government policies, environmental regulations, and trade restrictions affect Haemorrhoid Ligators (rubber band ligation) Sales and market dynamics?

Related Studies:

Temporomandibular joint (TMJ) implant Market
https://datavagyanik.com/reports/temporomandibular-joint-tmj-implant-market/

Bovine Pericardial Patch Market
https://datavagyanik.com/reports/bovine-pericardial-patch-market/

Ossicular prosthesis implants Market
https://datavagyanik.com/reports/ossicular-prosthesis-implants-market/

Retrievable inferior vena cava (IVC) filters Market
https://datavagyanik.com/reports/retrievable-inferior-vena-cava-ivc-filters-market/

Coronary Atherectomy Devices Market
https://datavagyanik.com/reports/coronary-atherectomy-devices-market/

IT Park, Dehradun, UK

Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.

Contact us:

Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/
Email: sales@datavagyanik.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Haemorrhoid Ligators (rubber band ligation) Market Size, Sales, Average Price and Trends Analysis, till 2032 here

News-ID: 4012914 • Views:

More Releases from Datavagyanik Business Intelligence

Beta-Sitosterol Supplements Market Size, Clinical Trials, Product Pipelines and Investment Trends, till 2032
Beta-Sitosterol Supplements Market Size, Clinical Trials, Product Pipelines and …
Beta-Sitosterol Supplements Market Size is estimated to be $670 million in 2024 and is expected to grow at an average yearly rate of around 9% during the timeframe (2025-2032). What is Beta-Sitosterol Supplements and what are the growth drivers of Beta-Sitosterol Supplements Market? Beta-sitosterol is a naturally occurring plant sterol found in fruits, vegetables, nuts, and seeds. Structurally similar to cholesterol, it competes with dietary cholesterol
Cranberry-based Supplements Market Size, Clinical Trials, Product Pipelines and Investment Trends, till 2032
Cranberry-based Supplements Market Size, Clinical Trials, Product Pipelines and …
Cranberry-based Supplements Market Size is estimated to be $1040 million in 2024 and is expected to grow at an average yearly rate of around 8% during the timeframe (2025-2032). What is Cranberry-based Supplements and what are the growth drivers of Cranberry-based Supplements Market? Cranberry-based supplements are dietary products formulated from cranberry fruit-most commonly Vaccinium macrocarpon-available in various forms such as tablets, capsules, powders, and liquid extracts. These supplements either contain
Lipase Inhibitors Market Size, Clinical Trials, Product Pipelines and Investment Trends, till 2032
Lipase Inhibitors Market Size, Clinical Trials, Product Pipelines and Investment …
Lipase Inhibitors Market Size is estimated to be $945 million in 2024 and is expected to grow at an average yearly rate of around 6% during the timeframe (2025-2032). What is Lipase Inhibitors and what are the growth drivers of Lipase Inhibitors Market? Lipase inhibitors are compounds that block the activity of lipase, an enzyme responsible for breaking down dietary fats in the digestive system. By inhibiting lipase, these substances
Tricyclic Antidepressants Market Size, Clinical Trials, Product Pipelines and Investment Trends, till 2032
Tricyclic Antidepressants Market Size, Clinical Trials, Product Pipelines and In …
Tricyclic Antidepressants Market Size is estimated to be $4950 million in 2024 and is expected to grow at an average yearly rate of around 7% during the timeframe (2025-2032). What is Tricyclic Antidepressants and what are the growth drivers of Tricyclic Antidepressants Market? Tricyclic antidepressants (TCAs) are a class of medications primarily used to treat major depressive disorder. They are among the earliest forms of antidepressants

All 5 Releases


More Releases for Haemorrhoid

Haemorrhoids Treatment Market CAGR of 11.88% during the forecast period.
Haemorrhoids Treatment Market (CHO) Cells Market to reach USD 2.37 Billion by 2031 This Haemorrhoids Treatment Market (CHO) Cells Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It
Haemorrhoids Treatment Market is Expected to Undergo a CAGR of 11.88% During the …
This Haemorrhoids Treatment market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics,
Haemorrhoids Treatment Market is Expected to Undergo a CAGR of 11.88% During the …
This Haemorrhoids Treatment market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics,
Haemorrhoids Treatment Market Share, Size, CAGR, Growth, Analysis, Worth, Trends …
A wide-reaching Haemorrhoids Treatment Market research report brings into focus the key market dynamics of the sector. This market study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, distributors, and Porter's Five Forces Analysis. The report provides fluctuations in CAGR values during the forecast period of the market. The transformation in the market landscape is mainly observed due
Haemorrhoids Treatment Market Share, Size, CAGR, Growth, Analysis, Worth, Trends …
A wide-reaching Haemorrhoids Treatment Market research report brings into focus the key market dynamics of the sector. This market study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, distributors, and Porter's Five Forces Analysis. The report provides fluctuations in CAGR values during the forecast period of the market. The transformation in the market landscape is mainly observed due
Hemorrhoid Treatment Devices Market Size is expected to reach at USD 1,074 Milli …
Hemorrhoid Treatment Devices Market Outlook In 2021, the market for haemorrhoid treatment equipment was worth US$728.9 Mn. From 2023 to 2032, the global market is anticipated to expand at a CAGR of 5.7%. By the end of 2032, it is expected that the market for haemorrhoid treatment devices would have grown to more than US$ 1.2 billion. Hemorrhoid Treatment Devices Market Overview An adult-predominant intestinal disorder called a haemorrhoid. Veins close to the